Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK/PD”

Showing 20 of 0 results

Not applicableStudy completedNCT02877628
What this trial is testing

Immunosuppressive Therapy Optimization: Development of a Population Pharmacokinetic-pharmacodynamic (PK-PD) Model in Liver Transplantation

Who this might be right for
Liver Transplantation
Rennes University Hospital 110
Not applicableNot Yet RecruitingNCT07769567
What this trial is testing

Optimization of Therapeutic Drug Monitoring in Pediatric Kidney Transplant

Who this might be right for
Kidney Transplant
Children's Hospital Medical Center, Cincinnati 25
Early research (Phase 1)Study completedNCT04235439
What this trial is testing

PK/PD Biosimilarity Study of Gan & Lee Insulin Lispro Injection vs. EU and US Humalog® in Healthy Males

Who this might be right for
Diabetes Mellitus
Gan and Lee Pharmaceuticals, USA 36
Testing effectiveness (Phase 2)Study completedNCT01304277
What this trial is testing

This Study is Designed to Evaluate PD/PK and Safety of Replagal Manufactured by Two Different Processes.

Who this might be right for
Fabry Disease
Shire 17
Testing effectiveness (Phase 2)Study completedNCT00624442
What this trial is testing

CK-1827452 Infusion in Stable Heart Failure

Who this might be right for
Heart Failure
Cytokinetics 45
Very early researchStudy completedNCT01722669
What this trial is testing

Quercetin PK/PD Study in Healthy Adults and Patients With Hypercoagulable States

Who this might be right for
Healthy
Beth Israel Deaconess Medical Center 38
Testing effectiveness (Phase 2)Looking for participantsNCT07005180
What this trial is testing

Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease

Who this might be right for
Parkinson Disease
Hillhurst Biopharmaceuticals, Inc. 36
Early research (Phase 1)Study completedNCT03882112
What this trial is testing

Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Male Subjects

Who this might be right for
Heathy Volunteer
Hanmi Pharmaceutical Company Limited 24
Testing effectiveness (Phase 2)Study completedNCT00913653
What this trial is testing

Safety/Tolerability, Pharmacokinetics/Pharmacodynamics (PK/PD) of LCZ696 in Patients With Stable Heart Failure

Who this might be right for
Heart Failure
Novartis Pharmaceuticals 30
Post-approval studies (Phase 4)Study completedNCT02403830
What this trial is testing

Effect of Methylnaltrexone on the PK/PD Profiles of Ticagrelor in Patients Treated With Morphine

Who this might be right for
Coronary Artery Disease
University of Florida 30
Not applicableStudy completedNCT03798600
What this trial is testing

Pharmacokinetics/Pharmacodynamics (PK/PD) of Caspofungin in Intensive Care Unit (ICU) Patients. An Open Observational Study for Antifungal Treatment's Optimization

Who this might be right for
Critical IllnessInfection
Careggi Hospital 20
Very early researchEnded earlyNCT05438667
What this trial is testing

TCR-T Cell Therapy on Advanced Solid Tumors

Who this might be right for
Pancreatic Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 1
Testing effectiveness (Phase 2)Study completedNCT02476019
What this trial is testing

A Safety, Tolerability, PK, and PD Study of Once Weekly ISIS-FGFR4RX SC in Obese Patients

Who this might be right for
Obesity
Ionis Pharmaceuticals, Inc. 13
Early research (Phase 1)Study completedNCT01741519
What this trial is testing

Long-term PK and Safety/Tolerability Testing LDLL600 Against Esmolol in Healthy Volunteers

Who this might be right for
Healthy
AOP Orphan Pharmaceuticals AG 14
Testing effectiveness (Phase 2)Ended earlyNCT03573544
What this trial is testing

This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors.

Who this might be right for
Metastatic Solid TumorsLocally Advanced Solid Tumors
OBI Pharma, Inc 54
Early research (Phase 1)Study completedNCT04488900
What this trial is testing

Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects

Who this might be right for
Healthy Subjects
Chong Kun Dang Pharmaceutical 88
Testing effectiveness (Phase 2)Study completedNCT04311632
What this trial is testing

A Dose Escalation Study in de Novo Renal Transplantation

Who this might be right for
Kidney Transplantation
ITB-Med LLC 13
Testing effectiveness (Phase 2)Study completedNCT03334058
What this trial is testing

Evaluate the Safety, PD, PK and Efficacy of ARGX-113 in Patients With Pemphigus

Who this might be right for
Pemphigus VulgarisPemphigus Foliaceus
argenx 34
Not applicableLooking for participantsNCT06718517
What this trial is testing

Impact of a TDM-guided ECPA Program for Optimizing Pharmacodynamic Target Attainment of Continuous Infusion Beta-lactam-based Regimen

Who this might be right for
Liver Transplant Infection
IRCCS Azienda Ospedaliero-Universitaria di Bologna 65
Early research (Phase 1)Looking for participantsNCT06366789
What this trial is testing

Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
AML With Gene Mutations
Lomond Therapeutics Holdings, Inc. 150
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation